Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Lung Cancer

• Publication date

  2007-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.LUNGCAN.2007.07.004PMID 17714826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix metalloproteinases and tumor metastasis

  2006cited by this paper
• Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer.

  2006cited by this paper
• HER-2/neu Represses the Metastasis Suppressor RECK via ERK and Sp Transcription Factors to Promote Cell Invasion*

  2006cited by this paper
• Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.

  2006cited by this paper
• Cancer Statistics, 2005

  2005cited by this paper
• The Membrane-Anchored Matrix Metalloproteinase (MMP) Regulator RECK in Combination with MMP-9 Serves as an Informative Prognostic Indicator for Colorectal Cancer

  2004cited by this paper
• Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer.

  2004cited by this paper
• Matrix metalloproteinase inhibitor reversion‐inducing cysteine‐rich protein with Kazal motifs

  2003cited by this paper
• RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.

  2003influential reference
• RECK: A novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling

  2003cited by this paper
• Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells

  2002cited by this paper
• RECKing MMP function: implications for cancer development.

  2002cited by this paper
• Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis

  2001cited by this paper
• The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis

  2001cited by this paper
• RECK gene expression in hepatocellular carcinoma: Correlation with invasion‐related clinicopathological factors and its clinical significance

  2001cited by this paper
• Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

  2000cited by this paper
• Oncogene-mediated downregulation of RECK, a novel transformation suppressor gene.

  1999cited by this paper
• Histological Typing of Lung and Pleural Tumours

  1999cited by this paper
• Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK.

  1998influential reference
• Identification and Characterization of a Novel Human Matrix Metalloproteinase with Unique Structural Characteristics, Chromosomal Location, and Tissue Distribution*

  1997cited by this paper
• Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.

  1996cited by this paper
• Matrix metalloproteinases and their inhibitors in connective tissue remodeling

  1991cited by this paper
• Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes.

  1989cited by this paper
• A ras-related gene with transformation suppressor activity.

  1989cited by this paper

• Association between the Reduced Expression of RECK and Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease

  2024cites this paper
• Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes

  2023cites this paper
• The Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASH

  2021cites this paper
• Expression and localization of the MMP inhibitor RECK in a rat model of COPD: its involvement in the development of COPD.

  2020cites this paper
• Sinomenine Inhibits Migration and Invasion of Human Lung Cancer Cell through Downregulating Expression of miR-21 and MMPs

  2020cites this paper
• Dual-target inhibitors based on HDACs: Novel antitumor agents for cancer therapy.

  2020cites this paper
• Prognostic role of RECK in pathological outcome-dependent buccal mucosa squamous cell carcinoma.

  2019cites this paper
• RECK isoforms have opposing effects on cell migration

  2018cites this paper
• [Advances in the molecular mechanisms of perineural invasion in salivary adenoid cystic carcinoma].

  2018cites this paper
• Is dual inhibition of metalloenzymes HDAC‐8 and MMP‐2 a potential pharmacological target to combat hematological malignancies?

  2017cites this paper
• Expression of matrix metalloproteinases-2, -9 and reversion-inducing cysteine-rich protein with Kazal motifs in gingiva in periodontal health and disease.

  2017cites this paper
• Solasodine inhibits invasion of human lung cancer cell through downregulation of miR-21 and MMPs expression.

  2017cites this paper
• Grb2-associated binder 2 expression and its roles in uveal melanoma invasion

  2017cites this paper
• Potential Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of Matrix Metalloproteinases (MMPs) Expression in Periodontal Diseases

  2016cites this paper
• RECK is not an independent prognostic marker for breast cancer

  2015cites this paper
• β-Asarone inhibits gastric cancer cell proliferation.

  2015cites this paper
• RECK Gene Polymorphisms in Hepatocellular Carcinoma and Cirrhotic Patients Related to Hepatitis C Virus

  2015cites this paper
• Epigallocatechin‑3‑gallate inhibits the invasion of salivary adenoid cystic carcinoma cells by reversing the hypermethylation status of the RECK gene.

  2015cites this paper
• MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1

  2014cites this paper
• A novel compound RY10-4 induces apoptosis and inhibits invasion via inhibiting STAT3 through ERK-, p38-dependent pathways in human lung adenocarcinoma A549 cells.

  2014cites this paper
• Effects of 5-aza-2′deoxycytidine on RECK gene expression and tumor invasion in salivary adenoid cystic carcinoma

  2014cites this paper
• Development of a Flow-Cytometric Screening Method for MMP-14 Inhibitory Antibody

  2014influential citation
• Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets

  2013cites this paper
• Tomatidine inhibits invasion of human lung adenocarcinoma cell A549 by reducing matrix metalloproteinases expression.

  2013cites this paper
• RECKing MMP: relevance of reversion-inducing cysteine-rich protein with kazal motifs as a prognostic marker and therapeutic target for cancer (a review).

  2012cites this paper
• Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.

  2012cites this paper
• Estrogen suppresses expression of the matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs (RECK) within the mouse uterus

  2012cites this paper
• Impacts of CA9 Gene Polymorphisms and Environmental Factors on Oral-Cancer Susceptibility and Clinicopathologic Characteristics in Taiwan

  2012cites this paper
• The metalloproteinase inhibitor Reck is essential for zebrafish DRG development

  2012cites this paper
• Effect of RECK Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features

  2012cites this paper
• Aberrant Expression Levels of MTA1 and RECK in Nasopharyngeal Carcinoma: Association with Metastasis, Recurrence, and Prognosis

  2012cites this paper
• Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer.

  2012cites this paper
• Impact of RECK gene polymorphisms and environmental factors on oral cancer susceptibility and clinicopathologic characteristics in Taiwan.

  2011cites this paper
• Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling

  2011cites this paper
• Reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase-9 are prognostic markers in skull base chordomas

  2010cites this paper
• Caracterização do perfil de expressão de MMPs e de seus inibidores, TIMPs e Reck, em linhagens representativas dos diferentes estágios de progressão do melanona humano

  2010cites this paper
• Role of RECK methylation in gastric cancer and its clinical significance.

  2010cites this paper
• Expression of RECK gene in the osteosarcoma cell line and its correlation with MMP-2

  2009cites this paper
• Significance of methylation status and the expression of RECK mRNA in lung tissue of patients with NSCLC.

  2009cites this paper
• Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas.

  2008cites this paper
• Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK)

  2008cites this paper
• Expression of Reversion-inducing Cysteine-rich Protein with Kazal Motifs in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus: Links to Disease Activity, Damage Accrual and Matrix Metalloproteinase 9 Secretion

  2008cites this paper